These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 36689477)

  • 1. Bioactive Compounds from Brown Algae Alleviate Nonalcoholic Fatty Liver Disease: An Extensive Review.
    Wu Y; Jin X; Zhang Y; Liu J; Wu M; Tong H
    J Agric Food Chem; 2023 Feb; 71(4):1771-1787. PubMed ID: 36689477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brown-Algae Polysaccharides as Active Constituents against Nonalcoholic Fatty Liver Disease.
    Rashed ZE; Grasselli E; Khalifeh H; Canesi L; Demori I
    Planta Med; 2022 Jan; 88(1):9-19. PubMed ID: 33142346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioactive Components and Possible Activities of Medicinal Mushrooms in Alleviating the Pathogenesis of Nonalcoholic Fatty Liver Disease (Review).
    Lo HC
    Int J Med Mushrooms; 2021; 23(3):29-41. PubMed ID: 33822497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventive Efficiency of Green Tea and Its Components on Nonalcoholic Fatty Liver Disease.
    Zhou J; Ho CT; Long P; Meng Q; Zhang L; Wan X
    J Agric Food Chem; 2019 May; 67(19):5306-5317. PubMed ID: 30892882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nutrigenomics analysis reveals that copper deficiency and dietary sucrose up-regulate inflammation, fibrosis and lipogenic pathways in a mature rat model of nonalcoholic fatty liver disease.
    Tallino S; Duffy M; Ralle M; Cortés MP; Latorre M; Burkhead JL
    J Nutr Biochem; 2015 Oct; 26(10):996-1006. PubMed ID: 26033743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Nutraceutical Formulation Containing Brown Algae Reduces Hepatic Lipid Accumulation by Modulating Lipid Metabolism and Inflammation in Experimental Models of NAFLD and NASH.
    Gabbia D; Roverso M; Zanotto I; Colognesi M; Sayaf K; Sarcognato S; Arcidiacono D; Zaramella A; Realdon S; Ferri N; Guido M; Russo FP; Bogialli S; Carrara M; De Martin S
    Mar Drugs; 2022 Sep; 20(9):. PubMed ID: 36135761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Advances in the Regulatory Effects of Bioactive Compounds from Dietary Resources on Nonalcoholic Fatty Liver Disease: Role of Autophagy.
    Zhang Y; Chen Q; Fu X; Zhu S; Huang Q; Li C
    J Agric Food Chem; 2023 Nov; 71(46):17554-17569. PubMed ID: 37955247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multi-targeting strategy to ameliorate high-fat-diet- and fructose-induced (western diet-induced) non-alcoholic fatty liver disease (NAFLD) with supplementation of a mixture of legume ethanol extracts.
    Koh YC; Lin YC; Lee PS; Lu TJ; Lin KY; Pan MH
    Food Funct; 2020 Sep; 11(9):7545-7560. PubMed ID: 32815965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Takahashi Y; Sugimoto K; Inui H; Fukusato T
    World J Gastroenterol; 2015 Apr; 21(13):3777-85. PubMed ID: 25852263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Buchholzia coriacea seed (wonderful kolanut) alleviates insulin resistance, steatosis, inflammation and oxidative stress in high fat diet model of fatty liver disease.
    Ore A; Akinloye OA; Adeogun AI; Ugbaja RN; Morifi E; Makatini M; Moepya R; Mbhele T
    J Food Biochem; 2022 Mar; 46(3):e13836. PubMed ID: 34184286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phytotherapy as Multi-Hit Therapy to Confront the Multiple Pathophysiology in Non-Alcoholic Fatty Liver Disease: A Systematic Review of Experimental Interventions.
    Ore A; Akinloye OA
    Medicina (Kaunas); 2021 Aug; 57(8):. PubMed ID: 34441028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The American lifestyle-induced obesity syndrome diet in male and female rodents recapitulates the clinical and transcriptomic features of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Harris SE; Poolman TM; Arvaniti A; Cox RD; Gathercole LL; Tomlinson JW
    Am J Physiol Gastrointest Liver Physiol; 2020 Sep; 319(3):G345-G360. PubMed ID: 32755310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gallotannin Isolated from Pericarp of Water Caltrop Ameliorates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease in Mice.
    Lü H; Meng X; Ding X; Jian T; Zuo Y; Liu Y; Ren B; Li W; Chen J
    J Agric Food Chem; 2023 May; 71(18):7046-7057. PubMed ID: 37113100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fucoxanthin Attenuates Free Fatty Acid-Induced Nonalcoholic Fatty Liver Disease by Regulating Lipid Metabolism/Oxidative Stress/Inflammation via the AMPK/Nrf2/TLR4 Signaling Pathway.
    Ye J; Zheng J; Tian X; Xu B; Yuan F; Wang B; Yang Z; Huang F
    Mar Drugs; 2022 Mar; 20(4):. PubMed ID: 35447899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonalcoholic Fatty Liver Disease in Patients with Polycystic Ovary Syndrome.
    Macut D; Bjekić-Macut J; Livadas S; Stanojlović O; Hrnčić D; Rašić-Marković A; Milutinović DV; Mladenović V; Andrić Z
    Curr Pharm Des; 2018; 24(38):4593-4597. PubMed ID: 30652641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fucoidan and Fucoxanthin Attenuate Hepatic Steatosis and Inflammation of NAFLD through Modulation of Leptin/Adiponectin Axis.
    Shih PH; Shiue SJ; Chen CN; Cheng SW; Lin HY; Wu LW; Wu MS
    Mar Drugs; 2021 Mar; 19(3):. PubMed ID: 33809062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulated microRNA-130b-5p prevents lipid accumulation and insulin resistance in a murine model of nonalcoholic fatty liver disease.
    Liu X; Chen S; Zhang L
    Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E34-E42. PubMed ID: 32228319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Sitagliptin on Nonalcoholic Fatty Liver Disease in High-fat-diet-fed Diabetic Mice.
    Zhou ST; Cui W; Kong L; Yang X
    Curr Med Sci; 2022 Jun; 42(3):513-519. PubMed ID: 35451807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Huangqin decoction alleviates lipid metabolism disorders and insulin resistance in nonalcoholic fatty liver disease by triggering Sirt1/NF-κB pathway.
    Yan BF; Pan LF; Quan YF; Sha Q; Zhang JZ; Zhang YF; Zhou LB; Qian XL; Gu XM; Li FT; Wang T; Liu J; Zheng X
    World J Gastroenterol; 2023 Aug; 29(31):4744-4762. PubMed ID: 37664157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyphenol-Rich Fraction of Ecklonia cava Improves Nonalcoholic Fatty Liver Disease in High Fat Diet-Fed Mice.
    Park EY; Choi H; Yoon JY; Lee IY; Seo Y; Moon HS; Hwang JH; Jun HS
    Mar Drugs; 2015 Nov; 13(11):6866-83. PubMed ID: 26569269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.